oloBion
oloBion is a Barcelona-based CRO providing end-to-end mass spectrometry-based metabolomics, lipidomics, and proteomics services to over 1,000 researchers across pharma, biotech, academia, and seven life-science application verticals, supported by its proprietary AI-powered oloMAP bioinformatics platform.
- Company typePrivate
- Founded2020
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
What oloBion does
oloBion SL is a Barcelona-based Contract Research Organization founded in 2020 that provides end-to-end mass spectrometry-based multi-omics services, with a satellite laboratory at the UC Davis Genome Center in California and a New York sales office. The company offers metabolomics, lipidomics, proteomics (including Olink PEA-based targeted panels), ADME-DMPK, ionomics, caroteomics, and nutritional analysis across seven application verticals — pharmaceutical and biotechnology, biomedicine and health research, agriculture and food, cosmetics and dermatology, nutraceutical and nutrition, veterinary and animal science, and environmental and ecology.
The technical stack combines high-resolution mass spectrometry platforms (Agilent 6560 Ion Mobility Q-TOF, SCIEX ZenoTOF 7600 with Electron-Activated Dissociation, Agilent 7200 GC-MS, Agilent 1260 UPLC, Agilent 4210 MP-AES, LECO CN 8028) with the proprietary AI-powered bioinformatics platform oloMAP, backed by a database of more than one million biomolecules. oloMAP's 4D-ID® strategy uses machine learning to combine accurate mass, MS/MS fragmentation, retention time, and collision cross section for high-confidence lipid identification, and is delivered to clients through the oloMAP Portal web application for interactive data analysis and biological interpretation. The portal has received continuous feature updates from its 2024 launch through 2026, including pathway analysis, advanced statistics, and N-omics integration.
oloBion generates revenue through project-based analytical service contracts on a quote-based model with volume and multi-omics bundle discounts, alongside a 6-week standard delivery and fast-track option. The oloMAP Portal and Biological Interpretation Report function as premium add-ons that introduce subscription-like recurring revenue characteristics. The company serves more than 1,000 researchers in academia and industry worldwide, and supplements service revenue with non-dilutive grant funding from Eurostars programmes (LIPIDOMAB 2023-2025, NEUROSPARK €2.3M, 2026), CDTI, EU Horizon Europe, and the Spanish Pyme Innovadora certification. Quality systems are certified to ISO 9001:2015 and UNE-EN ISO/IEC 17025:2017 with Good Laboratory Practice compliance. The company is founder-controlled, with no disclosed institutional equity capital.
oloBion firmographics
Firmographics- Name
- oloBion
- Legal name
- oloBion SL
- Website
- https://olobion.ai
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- oloBion is a Barcelona-based CRO providing end-to-end mass spectrometry-based metabolomics, lipidomics, and proteomics services to over 1,000 researchers across pharma, biotech, academia, and seven life-science application verticals, supported by its proprietary AI-powered oloMAP bioinformatics platform.
- Ownership category
- akta.pro rank
oloBion industry classification
Industry- Product category
- Contract Research Organization (Omics Analytical Services)
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Metabolomics & Lipidomics Services (HLAGANAG)
Keywords
Where oloBion is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices3 records
Markets served
oloBion business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Omics Analytical Services (CRO): oloBion operates as a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services. Services include metabolomics, lipidomics, proteomics, ADME-DMPK, bioinformatics (oloMAP), Olink proteomics, ionomics, caroteomics, and nutritional analysis. Revenue is generated through project-based analytical service contracts with academic and industry clients. Pricing includes discounts associated with number of samples and multi-omics analysis, with standard 6-week delivery and fast-track options.
- Bioinformatics Software Services (oloMAP Portal): oloMAP Portal provides bioinformatics data analysis and interpretation as part of the integrated omics service offering. The platform offers single-omics and multi-omics analyses with Advanced Statistics and Biological Interpretation Reports as premium add-ons, supporting the core analytical service revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based analytical services with volume and multi-omics discounts |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels8 records
oloBion product offering
Product offeringCore offering
oloBion is a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services, including metabolomics, lipidomics, proteomics, ADME-DMPK, ionomics, caroteomics, and nutritional analysis. Sample preparation through biological interpretation is delivered as an integrated service, powered by the proprietary AI-driven oloMAP bioinformatics platform and a database of over one million biomolecules. The company serves academic and industry clients across seven application verticals from its laboratories in Barcelona (Spain) and at UC Davis (USA).
Product overview
oloBion is a science-based CRO (Contract Research Organization) providing end-to-end mass spectrometry–based omics services, including metabolomics, lipidomics, proteomics, ADME–DMPK, ionomics, caroteomics, and nutritional analysis. The offering is organized as a multi-layered portfolio: at the core is the proprietary AI-powered bioinformatics platform oloMAP, which powers all data processing and biomolecule identification using a database of over 1 million biomolecules, and its web-based interface oloMAP Portal for interactive data analysis, visualization, and biological interpretation. oloMAP Portal supports both single-omics and multi-omics integration workflows. The analytical infrastructure is anchored by advanced mass spectrometry platforms — the Agilent 6560 Ion Mobility Q-TOF LC/MS (metabolomics), SCIEX ZenoTOF 7600 with EAD technology (lipidomics/proteomics), Agilent 7200 GC-MS, Agilent 4210 MP-AES, Agilent 1260 UPLC, and LECO CN 8028 — complemented by Olink® PEA-based targeted proteomics as an authorized service provider. oloBion also offers specialized ADME–DMPK services and a Biological Interpretation Report add-on. Services span seven application verticals: Pharmaceutical & Biotechnology, Biomedicine & Health Research, Agriculture & Food, Cosmetics & Dermatology, Nutraceutical & Nutrition, Veterinary & Animal Science, and Environmental & Ecology. The company is ISO 9001:2015 certified and participates in funded research projects including LIPIDOMAB (Eurostars) and NEUROSPARK (Eurostars).
Differentiator
Problem solved
Functional benefit
Brands
- oloMAP: AI-powered bioinformatics platform for omics data processing, annotation, and visualization
- oloMAP Portal
- oloMAP 4D-ID®
Products and services
- oloMAP Bioinformatics Platform Proprietary AI-powered bioinformatics platform for high-throughput metabolomics, lipidomics and proteomics data processing, high-confidence feature annotation and identification, powered by a proprietary database of over one million biomolecules.
- oloMAP Portal Interactive web-based platform for omics data analysis and interpretation, integrating statistical analysis with data visualization and supporting single-omics, multi-omics, and N-omics integration for in-depth biological exploration.
- Lipidomics Services
Quantifiable outcome
- Standard delivery time of 6 weeks with fast-track option available, enabling predictable research timelines
- +2 more outcomes
Companies that use oloBion
Customer profileNamed customers28 records
Segments7 records
Ideal customer profiles5 records
oloBion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
oloBion partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- InVirtuoLabscoreoloBion is a partner in the NEUROSPARK Eurostars grant project (€2.3M, 36 months) led by InVirtuoLabs, alongside 7hc (Italy) and INSYBIO (Greece). The project aims to identify and validate 3-5 lead small molecules for Spinocerebellar Ataxia Type 3 (SCA3), a rare neurodegenerative movement disorder, using AI-based Virtual Cell Models as digital twins of diseased cells.
- 7hc (Italy)corePartner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.
- INSYBIO (Greece)corePartner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.
- IRB Barcelona (Institute for Research in Biomedicine)coreoloBion and IRB Barcelona entered into a collaboration agreement for advanced metabolomic, proteomic and lipidomic analyses on murine and human tissue and biological fluid samples. The partnership supports the Stem Cell and Cancer laboratory led by Dr. Salvador Aznar Benitah, focusing on metabolic alterations in cancer models (oral squamous cell carcinoma, triple-negative breast cancer) and metabolically relevant tissues (liver, muscle, adipose tissue). IRB Barcelona gains access to high-quality omics datasets for biological understanding and molecular signature identification.
- Nutrialitec ConsortiumcoreoloBion is part of the Nutrialitec consortium, co-funded by CDTI and NextGeneration EU (Plan de Recuperación, Transformación y Resiliencia). Partners include Centro Tecnológico Nacional de la Conserva y Alimentación (CTNC), CTAEX, Basque Culinary Center Innovation, UCAM, and Artica+i. Focus on food technology and nutrition innovation research.
- LIPIDOMAB Eurostars ProjectcoreoloBion participated in the LIPIDOMAB Eurostars project (CIIP-20232025) focused on accelerating development of a first-in-class antibody blocking lipid metabolism for treatment of advanced cancer through novel breakthrough technologies. Project received co-funding from CDTI and EU Horizon Europe.
- OlinkcoreoloBion is an official Olink Certified Service Provider for Olink Target and Olink Flex proteomics products. The company has passed Olink certification testing and integrates Olink proximity extension assay (PEA) technology with its own LC-MS proteomics and multi-omics services for comprehensive proteomics solutions.
- Atens (Agrotecnologias Naturales SL)minorAtens is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Atens develops agricultural biotechnologies and natural agricultural solutions.
- Hello-Nature GroupminorHello-Nature Group is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Hello-Nature focuses on agricultural and nutritional solutions.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
oloBion competitors and assessment
Company assessmentDirect peers
- Metabolon: Metabolon is a leading metabolomics CRO offering global Precision Metabolomics profiling services to pharma, biotech, and academic clients. It is the most directly comparable scaled competitor to oloBion in the metabolomics services market.
- Creative Proteomics: Creative Proteomics offers metabolomics, lipidomics, and proteomics services to academic and industry researchers globally. Directly comparable as a multi-omics CRO competing for similar project-based engagements.
- Biocrates Life Sciences: Biocrates provides standardized metabolomics and lipidomics kits and CRO services focused on quantitative targeted metabolomics. Comparable to oloBion as a specialized metabolomics/lipidomics service provider with proprietary assay panels.
- Lipotype: Lipotype is a lipidomics-focused CRO providing mass spectrometry-based lipid analysis for academic and industry clients. Directly comparable to oloBion's lipidomics specialization and 4D-ID®-style structural characterization.
Broad incumbents
- Evotec: Evotec is a global drug discovery CRO with multi-omics, biomarker, and DMPK capabilities. Comparable as a broad incumbent competing for outsourced discovery budgets that oloBion serves in pharma/biotech.
- Eurofins Discovery: Eurofins Discovery is a large, diversified CRO offering ADME-DMPK, metabolomics, and biomarker services through its Discovery and Pharma Discovery franchises. Comparable to oloBion on ADME-DMPK and analytical services, but with far broader portfolio and scale.
- Bruker: Bruker is a leading mass spectrometry and NMR instrumentation vendor offering timsTOF-based 4D-omics solutions and increasingly services/applications support. Comparable as a technology incumbent in ion-mobility-based omics that competes at the platform level.
- Olink (part of Thermo Fisher Scientific): Olink provides proximity extension assay (PEA) proteomics technology and a network of certified service providers. Comparable as the technology incumbent behind the proteomics platform oloBion offers as a Certified Service Provider.
- Charles River Laboratories: Charles River is a global CRO with discovery, safety assessment, and manufacturing services including preclinical DMPK capabilities. Comparable as a broad incumbent that competes for preclinical ADME-DMPK and discovery budgets.
Regional players
- West Coast Metabolomics Center (UC Davis): WCMC is an NIH-funded metabolomics core at UC Davis directed by Oliver Fiehn (oloBion's Metabolomics Advisor). It is co-located with oloBion's Davis lab and overlaps in metabolomics services and training offerings.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
oloBion social profiles
Digital presenceoloBion compliance and trust
Trust signalCompliance3 records
oloBion financial estimates
Financial estimateRevenue estimate
Valuation estimate
oloBion leadership team
Management profileNumber of profiles
Profiles11 records
oloBion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
oloBion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about oloBion
What does oloBion do?
oloBion is a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services, including metabolomics, lipidomics, proteomics, ADME-DMPK, ionomics, caroteomics, and nutritional analysis. Sample preparation through biological interpretation is delivered as an integrated service, powered by the proprietary AI-driven oloMAP bioinformatics platform and a database of over one million biomolecules. The company serves academic and industry clients across seven application verticals from its laboratories in Barcelona (Spain) and at UC Davis (USA).
Is oloBion a public or private company?
oloBion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was oloBion founded?
oloBion was founded in 2020. It employs 1 to 10 people.
Where is oloBion based?
oloBion is headquartered in Barcelona, Spain, in the Europe region.
How does oloBion make money?
Two revenue lines are on record. Omics Analytical Services (CRO) is the primary driver. The others are bioinformatics Software Services (oloMAP Portal).
Who are oloBion's main competitors?
Direct peers on record are Metabolon, Creative Proteomics, Biocrates Life Sciences and Lipotype. Broad incumbents are Evotec, Eurofins Discovery, Bruker, Olink (part of Thermo Fisher Scientific) and Charles River Laboratories. West Coast Metabolomics Center (UC Davis) is listed as a regional player.
Does oloBion have an API?
No public API is recorded for oloBion.
What industry is oloBion in?
oloBion's product category is Contract Research Organization (Omics Analytical Services). Its primary akta.pro industry code is HLAGANAG, Metabolomics & Lipidomics Services. Its NAICS code is 54171 and its SIC code is 8731.